These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33743586)

  • 1. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.
    Zhang J; Li K; Pan L; Teng F; Zhang P; Lin B; Yuan Y; Wei X; Li W; Zhang H
    BMC Gastroenterol; 2021 Mar; 21(1):131. PubMed ID: 33743586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adipsin is associated with asymptomatic carotid atherosclerosis in obese adults.
    Zhang J; Teng F; Pan L; Guo D; Liu J; Li K; Yuan Y; Li W; Zhang H
    BMC Cardiovasc Disord; 2021 Oct; 21(1):517. PubMed ID: 34696714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study.
    Qiu Y; Wang SF; Yu C; Chen Q; Jiang R; Pei L; Huang YL; Pang NZ; Zhang Z; Ling W; Yang L
    Ann Nutr Metab; 2019; 74(1):44-52. PubMed ID: 30541001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study.
    Gu Y; Luo J; Chen Q; Qiu Y; Zhou Y; Wang X; Qian X; Liu Y; Xie J; Xu Z; Ling W; Chen Y; Yang L
    Ann Nutr Metab; 2022; 78(1):21-32. PubMed ID: 34814152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.
    Ju DY; Choe YG; Cho YK; Shin DS; Yoo SH; Yim SH; Lee JY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
    Clin Mol Hepatol; 2013 Jun; 19(2):140-7. PubMed ID: 23837138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in Obese Nigerians: A Cross-Sectional Study.
    Onyia CP; Asogwa P; Adiri W; Obienu O; Ijoma UN; Nwokediuko SC; Okeke EN
    Niger J Clin Pract; 2024 Mar; 27(3):352-360. PubMed ID: 38528356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
    Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
    Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.
    Wu LM; He H; Chen G; Kuang Y; Lin BY; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):252-257. PubMed ID: 32205038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): A case-control study.
    Tutunchi H; Mobasseri M; Aghamohammadzadeh N; Hooshyar J; Naeini F; Najafipour F
    Int J Clin Pract; 2021 Oct; 75(10):e14555. PubMed ID: 34159710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of reflux esophagitis in non-obese individuals with nonalcoholic fatty liver disease: a cross-sectional study.
    Qiu P; Du J; Zhang C; Li M; Li H; Chen C
    Ann Med; 2023; 55(2):2294933. PubMed ID: 38109930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
    Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.